My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

79.40 +2.07 (+2.68%)
Streaming Delayed Price Updated: 3:16 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,301,760
Open 78.70
Bid (Size) 79.37 (3)
Ask (Size) 79.43 (2)
Prev. Close 77.33
Today's Range 77.57 - 79.88
52wk Range 31.36 - 97.79
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Analysts Have This To Say About Tempus AI
Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings,... 
Via Benzinga
Topics Artificial Intelligence
Why Tempus AI Stock Is Plunging This Week
When a well-known growth investor decides to trim her position in a stock, investors sit up and take note. 
Via The Motley Fool
Topics Artificial Intelligence ETFs

Performance

YTD
+131.8%
+131.8%
1 Month
+4.1%
+4.1%
3 Month
+16.2%
+16.2%
6 Month
+52.8%
+52.8%
1 Year
+61.5%
+61.5%

More News

Read More
Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Woth $11 Million, Dumps AMD And This AI Stock
Via Benzinga
Topics Artificial Intelligence
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead
Via Benzinga
Topics Artificial Intelligence
IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance
Via Investor's Business Daily
Topics Artificial Intelligence Intellectual Property
Tempus AI (TEM) Stock Is Rising Monday: What's Going On?
Via Benzinga
Topics Artificial Intelligence
3 Big Short Interest Names with Bullish Setups
Via MarketBeat
Topics Artificial Intelligence
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
From Tempus AI, Inc.
Via Business Wire
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
Via Benzinga
Topics Artificial Intelligence
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
Via FinancialNewsMedia
Topics Artificial Intelligence
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI
Via Benzinga
What's Going On With Tempus AI Stock Monday?
Via Benzinga
Topics Artificial Intelligence
Cathie Wood's Ark Pivots: Sells Tempus AI After FDA Win, Loads Up On Amazon, Figma And This Trendy Crypto Stock
Via Benzinga
Topics Artificial Intelligence
Why Tempus AI Stock Soared Nearly 14% Higher Today
Via The Motley Fool
Topics Artificial Intelligence
Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging
Via Benzinga
Topics Artificial Intelligence
Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move
Via Investor's Business Daily
Topics Artificial Intelligence
Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
From Tempus AI, Inc.
Via Business Wire
Why Are Stock Market Investors Talking About TempusAI Stock?
Via The Motley Fool
Topics Artificial Intelligence
Stock Market Investors Want to Know: What's Going on With TempusAI Stock?
Via The Motley Fool
Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost
Via Benzinga
Topics Artificial Intelligence ETFs
Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer
From Tempus AI, Inc.
Via Business Wire
TEMPUS AI INC (NASDAQ:TEM) Excels on Minervini Trend Template with High Growth Momentum
Via Chartmill
Topics Artificial Intelligence
Northwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, Into Its EHR Platform
From Tempus AI, Inc.
Via Business Wire
Tempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference
From Tempus AI, Inc.
Via Business Wire

Frequently Asked Questions

Is Tempus AI, Inc. - Class A Common Stock publicly traded?
Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
What is the current price of Tempus AI, Inc. - Class A Common Stock?
The current price of Tempus AI, Inc. - Class A Common Stock is 79.40
When was Tempus AI, Inc. - Class A Common Stock last traded?
The last trade of Tempus AI, Inc. - Class A Common Stock was at 09/26/25 03:16 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.